tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market
BBOT
BridgeBio Oncology Therapeutics
RESEARCH TOOLSreports

BridgeBio Oncology Therapeutics (BBOT) Ratios

Compare
21 Followers

BridgeBio Oncology Therapeutics Ratios

BBOT's free cash flow for Q3 2025 was $―. For the 2025 fiscal year, BBOT's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.33 0.00 0.00 0.00-
Quick Ratio
 0.33 0.00 0.00 0.00-
Cash Ratio
 0.25 0.00 0.00 0.00-
Solvency Ratio
 0.58 -0.11 -0.02 -0.27-
Operating Cash Flow Ratio
 -0.44 0.00 0.00--
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00--
Net Current Asset Value
$ -7.27M$ -396.46K$ -166.46K$ -162.64K-
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.21 0.30 0.26-
Debt-to-Equity Ratio
 0.00 -1.10 -1.97 -2.01-
Debt-to-Capital Ratio
 0.00 10.74 2.03 1.99-
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00-
Financial Leverage Ratio
 -27.14 -5.24 -6.61 -7.86-
Debt Service Coverage Ratio
 0.00 -0.59 -0.08 -1.17-
Interest Coverage Ratio
 0.00 0.00 0.00 0.00-
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01-
Interest Debt Per Share
 0.00 <0.01 <0.01 <0.01-
Net Debt to EBITDA
 0.16 -1.68 -12.25 -0.85-
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%-
EBIT Margin
0.00%0.00%0.00%0.00%-
EBITDA Margin
0.00%0.00%0.00%0.00%-
Operating Profit Margin
0.00%0.00%0.00%0.00%-
Pretax Profit Margin
0.00%0.00%0.00%0.00%-
Net Profit Margin
0.00%0.00%0.00%0.00%-
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-
Net Income Per EBT
100.00%100.00%100.00%100.00%-
EBT Per EBIT
-120.70%100.00%100.00%99.99%-
Return on Assets (ROA)
2.39%-12.52%-2.43%-30.05%-
Return on Equity (ROE)
5.15%65.59%16.09%236.19%-
Return on Capital Employed (ROCE)
-2.01%65.59%16.09%236.20%-
Return on Invested Capital (ROIC)
-2.01%-638.86%-16.58%-233.07%-
Return on Tangible Assets
2.39%-12.52%-2.43%-30.05%-
Earnings Yield
1.62%-0.02%>-0.01%-0.02%-
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00-
Payables Turnover
 0.00 0.00 0.00 0.00-
Inventory Turnover
 0.00 0.00 0.00 0.00-
Fixed Asset Turnover
 0.00 0.00 0.00 0.00-
Asset Turnover
 0.00 0.00 0.00 0.00-
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00-
Cash Conversion Cycle
 0.00 0.00 0.00 0.00-
Days of Sales Outstanding
 0.00 0.00 0.00 0.00-
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00-
Days of Payables Outstanding
 0.00 0.00 0.00 0.00-
Operating Cycle
 0.00 0.00 0.00 0.00-
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.05 0.00 0.00--
Free Cash Flow Per Share
 -0.05 0.00 0.00--
CapEx Per Share
 0.00 0.00 0.00--
Free Cash Flow to Operating Cash Flow
 1.00 0.00 0.00 0.00-
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00-
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00-
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00--
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00-
Free Cash Flow Yield
-0.12%0.00%0.00%--
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 61.59 -5.01K -59.30K -4.81K-
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00-
Price-to-Book (P/B) Ratio
 -39.96 -3.28K -9.54K -11.37K-
Price-to-Free Cash Flow (P/FCF) Ratio
 -859.50 0.00 0.00 0.00-
Price-to-Operating Cash Flow Ratio
 -252.61 0.00 0.00 0.00-
Price-to-Earnings Growth (PEG) Ratio
 -3.57 -5.56 655.44 0.00-
Price-to-Fair Value
 -39.96 -3.28K -9.54K -11.37K-
Enterprise Value Multiple
 -237.66 -5.01K -59.31K -4.82K-
Enterprise Value
 988.00M 208.81M 208.79M 208.78M-
EV to EBITDA
 -237.66 -5.01K -59.31K -4.82K-
EV to Sales
 0.00 0.00 0.00 0.00-
EV to Free Cash Flow
 -858.93 0.00 0.00 0.00-
EV to Operating Cash Flow
 -858.93 0.00 0.00 0.00-
Tangible Book Value Per Share
 8.05 >-0.01 >-0.01 >-0.01-
Shareholders’ Equity Per Share
 -0.31 >-0.01 >-0.01 >-0.01-
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00-
Revenue Per Share
 0.00 0.00 0.00 0.00-
Net Income Per Share
 0.20 >-0.01 >-0.01 >-0.01-
Tax Burden
 1.00 1.00 1.00 1.00-
Interest Burden
 -1.13 1.00 1.00 1.00-
Research & Development to Revenue
 0.00 0.00 0.00 0.00-
SG&A to Revenue
 0.00 0.00 0.00 0.00-
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00-
Income Quality
 -0.24 0.00 0.00 0.00-
Currency in USD